Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection

Journal of Virological Methods

Volumn 146, Issue 1-2, 2007, Pages 409-413

  Enders, Martin ^a   Helbig, Sabine ^a   Hunjet, Andrea ^a   Pfister, Heiko ^b   Reichhuber, Christine ^b   Motz, Manfred ^b  

^a Labor Enders und Partner   (Germany)

^b MIKROGEN GMBH   (Germany)

Author keywords

B19; Diagnostic; EIA; Parvovirus; Pregnancy; Serology

Indexed keywords

CAPSID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MATERNAL ANTIBODY; RECOMBINANT PROTEIN; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; BACULOVIRUS; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; ERYTHEMA INFECTIOSUM; FEMALE; FETUS HYDROPS; GESTATION PERIOD; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VIRUS DETECTION; YEAST;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CAPSID PROTEINS; CHILD; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN M; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

MIRIDAE; PARVOVIRUS;

EID: 35649009933     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.08.008     Document Type: Article

References (24)

1. Anderson M.J., Higgins P.G., Davis L.R., Willman J.S., Jones S.E., Kidd I.M., Pattison J.R., and Tyrrell D.A. Experimental parvoviral infection in humans. J. Infect. Dis. 152 (1985) 257-265
2. Beersma M.F., Claas E.C., Sopaheluakan T., and Kroes A.C. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. J. Clin. Virol. 34 (2005) 71-75
3. Best J.M., and Enders G. Laboratory diagnosis of rubella and congenital rubella. In: Banatvala J., and Peckham C. (Eds). Rubella Viruses (2007), Elsevier B.V 39-77
4. Chisaka H., Ito K., Niikura H., Sugawara J., Takana T., Murakami T., Terada Y., Okamura K., Shiroishi H., Sugamura K., and Yaegashi N. Clinical manifestations and outcomes of parvovirus B19 infection during pregnancy in Japan. Tohoku J. Exp. Med. 209 (2006) 277-283
5. Cohen B.J., and Bates C.M. Evaluation of 4 commercial test kits for parvovirus B19-specific IgM. J. Virol. Methods 55 (1995) 11-25
6. Cohen B.J., and Supran E.M. IgM serology for rubella and human parvovirus B19. Lancet i (1987) 393
7. de Jong E.P., de Haan T.R., Kroes A.C., Beersma M.F., Oepkes D., and Walther F.J. Parvovirus B19 infection in pregnancy. J. Clin. Virol. 36 (2006) 1-7
8. Doyle S., Kerr S., O'Keeffe G., O'Carroll D., Daly P., and Kilty C. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J. Virol. Methods 90 (2000) 143-152
9. Enders M., Weidner A., Zöllner I., Searle K., and Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenatal Diag. 24 (2004) 513-518
10. Enders M., Schalasta G., Baisch C., Weidner A., Pukkila L., Kaikkonen L., Lankinen H., Hedman L., Söderlund-Venermo M., and Hedman K. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics. J. Clin. Virol. 35 (2006) 400-406
11. Enders, M., Weidner, A., Rosenthal, T., Baisch, C., Hedman, L., Söderlund-Venermo, M., Hedman, K., in press. Improved diagnosis of gestational B19 parvovirus infection at the time of non-immune fetal hydrops. J. Infect. Dis.
12. Gray J.J., Cohen B.J., and Desselberger U. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. J. Virol. Methods 44 (1993) 11-23
13. Jordan J.A. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women. J. Clin. Microbiol. 38 (2000) 1472-1475
14. Kerr S., O'Keeffe G., Kilty C., and Doyle S. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J. Med. Virol. 57 (1999) 179-185
15. Lowin T., Raab U., Schroeder J., Franssila R., and Modrow S. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors. J. Vet. Med. B 52 (2005) 348-352
16. Miller E., Fairley C.K., Cohen B.J., and Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br. J. Obstet. Gynaecol. 105 (1998) 174-178
17. Musiani M., Zerbini M., Gentilomi G., Plazzi M., Gallinella G., and Venturosi S. Parvovirus B19 clearance from peripheral blood after acute infection. J. Infect. Dis. 172 (1995) 1360-1363
18. Pfrepper K.I., Enders M., and Motz M. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection. J. Vet. Med. B: Infect. Dis. Vet. Public Health 52 (2005) 362-365
19. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. Br. Med. J. 300 (1990) 1166-1170
20. Schild R.L., Bald R., Plath H., Eis-Hübinger A.M., Enders G., and Hansmann M. Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obstet. Gynecol. 13 (1999) 161-166
21. Saikawa T., Anderson S., Momoeda M., Kajigaya S., and Young N.S. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J. Virol. 67 (1993) 3004-3009
22. Söderlund M., Brown C.S., Spaan W.J.M., Hedman L., and Hedman K. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus. J. Infect. Dis. 172 (1995) 1431-1436
23. Yaegashi N. Pathogenesis of nonimmune hydrops fetalis caused by intrauterine B19 infection. Tohoku J. Exp. Med. 190 (2000) 65-82
24. Zuffi E., Manaresi E., Gallinella G., Gentilomi G.A., Venturoli S., Zerbini M., and Musiani M. Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans. Viral Immunol. 14 (2001) 151-158